Two potassium channel blockers (amiodarone and dequalinium) also potentiated the growth inhibitory effects of the breast cancer drug tamoxifen in two breast cancer cell lines (Abdul et al. 2003). The gene discussed is KCNA3; the disease is breast carcinoma.